I'm not a happy camper here, but you are talking rubbish, Mister! A total BS masked behind a perverse "objectivity" of yours. This is a highly speculative stock, often manipulative just like a wast majority of novice micro cap bios, but it is NOT a garbage company by any means! One needs to know the entire history of this Co. How it got where it is now - a highly promising area of personalized medicine and unique cancer testing. It is by FAR more advanced and diversified company than it was only a year ago with growing revenue, broad collaboration portfolio and a very promising pipeline of products. KB is a SOB for his good and good of the company but he will get where he wants to be and make it into a $1B market cap Co. in the next 2-3 years. Just stop polluting this board with your pseudo sincerity, move on!
Yeah, sure .. when 200 dma is crossed with such force with a "little help of a friend" it should've lit a red light to be careful ...formation my as*
So, we all know Berlin is a master of legal manipulation, that he was looking for a chance to raise funds, that he had a prospect on shelf for long time. So he instigated a flow of news coming back to back right when the chart was breaking 200DMA. He informed SEC, the more acute ones among us have SEC filings e-mailed in real time. Warning came up on Twitter before market open. Of course insiders knew and shorted like crazy day before. What is your point? You can't implicate Berlin in any wrong doing so do dozens of other micro cap bios. I am just as angry for a shear size of the ATM sale impending. Berlin is greedy and underhanded SOB who pulls this trick on us repeatedly, but he is not stupid, I assume he did not sell much as there will be more spikes down the line when new assays are out or other news, so he may sell less for more. I hope he sold not more than 1M shares this time. He needs to get the price settled and start moving up towards ER report by the end of March and continue higher, otherwise there will be no buyers even at 50% discount.
than was $14 million worth of stock which is around 3- 4 million shares at the current price but if sold within a prolonged period of time it might end up being only 2-3 million. It would be utterly stupid to sell it all now with all the impending news, organic revenue growth and the new tests coming online in 6 month. Berlin is greedy but he is not stupid.
That was supposed to be an ATM sale - it does not have an offering price, so it would be a really ostentatious crime and easily provable had ROSG accepted sale proceeds based on a fixed price well beyond what market was buying for. Cantor would've been obliged to show real market sales conducted in "controllable" manner and corresponding proceed accordingly. For it to illegally benefit from this crime it would've had to front run the sale.. this is so transparent and utterly criminal and instantly detectable by a monitoring authority, that Cantor could simply lose his business altogether. Had the intent been leaked to the cronies day before and they shorted and kept shorting up to this day is a different matter. That is also rather easy to unravel. Tim Sykes and his bunch had openly bragged about shorting the stock unmercifully especially on the spike instigated by Berlin. The shear size of the impending ATM was the best insurance that the price will collapse. It would be especially shocking to find out that Cantor have sold the entire $14M in stock offering in the last 5 trading sessions regardless of the brutal distraction of the shareholders value. It would be simply criminal and stupid, and would send a horrible message to the investors that Berlin does not believe that the price may rise in the near future or for a long time to come, so he agrees to hit the market with a huge dilution instead of selling each time a little bit at higher valuation achieved organically and not via this dirty P&D trick he had pulled on us again. ROSG is due to report ER on March 30-th. He will be asked about this treacherous endeavor with all pertinent conclusions. He had shown in the past a complete and callous disdain for the innocent shareholders regardless of his 'nice" thank you letters to shareholders. So the current back-stubbing act would completely destroy any trust and his personal credibility for the years to come. He appears to care less though....
BS man, Zacks focused on the future, which is exactly what they are supposed to do, with a rather extensive and detailed coverage of the ongoing developments, pipeline and timetables for the new products introductions and the potential revenue growth rate. Yes, it is highly volatile micro cap in an explosive area of personalized cancer medicine and they are claiming the turf. Yes the latest ATM was a untimely move, hope thy do not overdo it ant put the money into a good use.
Sorry, I was misled by a repeat publication by Fly on the Wall news service, so I corrected that post of mine into this updated comparison instead. Still useful isn't it?!
Last June 27, 2014 Barrington raised its price target for Rosetta Genomics shares to $10 citing the issuance of a U.S. patent covering both composition of matter and utility of MicroRNA miR-205 for diagnosis and treatment of prostate cancer. The firm viewed the patent as unexpected and reiterated an Outperform rating on the stock.
Since than ROSG has obtained a bunch of new patents, collaboration and joined marketing agreements including those already generating new revenue stream. With the extended pipe line, new test expected to be introduced by 3Q 2015 and actual patents to be used for actual drugs development via licensing the updated valuation by Zacks still sets the PPS to the same $10/share - quote:
"Based on our financial model, we think a P/E multiple of 25x is appropriate for Rosetta. If we apply this
P/E coupled with EPS of $1.31 in 2020, discounted at 25% for 5 years, we come up with our price target
of $10.50 per share. Our price target values Rosetta at $126 million in market cap, which we think is still
ROSG: Broad Patent Allowances Assure Sustainable Growth
We believe these two partnerships will generate significant revenue growth in the coming quarters.
Specifically, we expect revenue will grow 372% in 2H14. Revenue will reach $5.5 million in in 2015, an increase of 254%. Longer term, we model revenue will grow at a compound annual growth rate (CAGR) of 108% from 2014 to 2020, when revenue will reach $125 million.
The whole thing is not about buying the shares back at some point in the future, besides as of now the shares are sold (when they a sold) at a discount to at least the last $5 a share offering. Come a day they are so rich and bursting with free cash flow and money in the bank so they would contemplate a shares buy back the price of the initial offering wont be an issue. Why bother wasting your time on this futile discussion.
There are plenty of perfectly legal ways to manipulate a stock price of a highly volatile micro cap. Berlin can teach a master class of the superbly efficient skills he has been successfully applying for the last 4 years.
That issue is explained down lower in my thread - 972 K was sold some time ago under the previous ATM agreement of March 31, 2014 to sell $10M worth of stock out of which they sold only $4.2M before the expiration. Now they signed a new ATM agreement just like a shelf, but we do not know whether there was a sale yet under the new agreement. So keep calm!
ATM agreement took me by surprise they usually extend it in March, still timing of it was and is stupid as there were so many good news leading to believe that pps will go much higher ....
That was SEC reported data. Still timing of it was ill advised. Still here is an ATM agreement for a whooping $14M in the future.
That was an open information, but no one contested me on that, in fact some went along as no one reads SEC reports in details. I was mistaken by the language of it.
I feel there is a clarification due concerning the information conveyed in the latest Controlled Equity Offering agreement with Cantor Fitzgerald of Feb. 18, 2015.
- Rosetta have maintained in the past a roll over agreement with Cantor to sell equity " at the market" (ATM) within the framework of Prospectus of 12/19/2012
- On 22/03/2013 ROSG signed an agreement with Cantor for the sale of shares in an aggregate amount of $5,900,000 Amount of shares outstanding at the time of signing was - 9,097,348 ord. shares. Withing this agreement Cantor sold 1,559,537 shares at avg. price of $3.78 a share bringing the total shares outstanding to 10,731,904 shares.
- On 03/31/2014 ROSG signed a new ATM agreement for a total aggr. amount of $10,000,000 within which only 972,552 share were sold at avg. price of $4.31 per share bringing the total share outstanding to 11,762,420 shares.
- On 02/18/2015 the agreement was extended to an aggr. amount of $14,000,000
BUT THERE WERE NO SALES REPORTED within that latest agreement.
I owe an apology to everybody for erroneously claiming (due to my misunderstanding of the facts) that near 1M shares were sold into the pop on Feb. 17-th.
I am not a day trader, sat with this sht for near 3 years since $5 offering. You were ready just 3 days ago to jump out had the run continued. Now you are free to read the map and tea leafs whether there is sufficient evidence for a b\o soon or ever. I simply feel much more pessimistic after that ATM and especially its' size. It tells me Berlin is prepared to make it into a long term project deeping into our pockets for the life style support rather than counting on generating revenue.